The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein-mediated cell fusion

被引:15
|
作者
Chien, Miao-Ping [1 ]
Jiang, Shibo [2 ]
Chang, Ding-Kwo [1 ]
机构
[1] Acad Sinica, Inst Chem, Taipei 11529, Taiwan
[2] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA
来源
FASEB JOURNAL | 2008年 / 22卷 / 04期
关键词
gp120; shedding; NC-1 sensitive conformation; lipid and content mixing; recruitment; fusion peptide;
D O I
10.1096/fj.07-9576com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The function of HIV-1 HXB2 envelope (Env) glycoprotein (gp) was investigated by surface plasmon resonance and fluorescence imaging techniques. Strikingly, it was found that gp120 shedding requires the presence of the X4 coreceptor. A similar coreceptor requirement was observed for the membrane mixing and the Env recruitment on the cell surface. However, exposure and membrane penetration of the fusion peptide do not require X4 and occur within the first minute after incubation of Env with CD4 and/or X4. Analogously X4 was not required but enhanced binding of the fusion inhibitor. In contrast, bundle formation of the gp41 ectodomain, as monitored by NC-1, was accelerated by the presence of X4. The kinetics of these key post-Env binding events as determined in real time by fluorescence microscopic imaging, coupled with the differential coreceptor requirement, led to the proposition that gp120 shedding, which takes place from 1 to 10 min after engagement of receptor and coreceptor to Env, is a primary function of the coreceptor. The shedding of the surface subunits is needed for the subsequent processes including hemifusion, full fusion, and Env recruitment. The temporal order of these fusogenic steps allows construction of a refined model on the Env-mediated cell fusion event.
引用
收藏
页码:1179 / 1192
页数:14
相关论文
共 50 条
  • [41] KINETICS OF HIV-1 ENVELOPE GLYCOPROTEIN-MEDIATED FUSION OF INDIVIDUAL CELLS
    BLUMENTHAL, R
    DIMITROV, DS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 26 - 26
  • [42] Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues
    Bewley, CA
    Ray, S
    Cohen, F
    Collins, SK
    Overman, LE
    JOURNAL OF NATURAL PRODUCTS, 2004, 67 (08): : 1319 - 1324
  • [43] HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
    Qi, Qianqian
    Wang, Qian
    Chen, Weizao
    Du, Lanying
    Dimitrov, Dimiter S.
    Lu, Lu
    Jiang, Shibo
    EMERGING MICROBES & INFECTIONS, 2017, 6 : 1 - 7
  • [44] Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
    Hoffman, TL
    LaBranche, CC
    Zhang, WT
    Canziani, G
    Robinson, J
    Chaiken, I
    Hoxie, JA
    Doms, RW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) : 6359 - 6364
  • [45] High-Affinity Binding of Southern African HIV Type 1 Subtype C Envelope Protein, gp120, to the CCR5 Coreceptor
    Fromme, Bernhard J.
    Coetsee, Marla
    Van Der Watt, Pauline
    Chan, Mei-Chi
    Sperling, Karin M.
    Katz, Arieh A.
    Flanagan, Colleen A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (12) : 1527 - 1536
  • [46] Blocking HIV-1 envelope-mediated fusion with exogenous and engineered proteins and peptides
    Bewley, C
    PROTEIN SCIENCE, 2004, 13 : 56 - 56
  • [47] Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
    Bron, R
    Klasse, PJ
    Wilkinson, D
    Clapham, PR
    PelchenMatthews, A
    Power, C
    Wells, TNC
    Kim, J
    Peiper, SC
    Hoxie, JA
    Marsh, M
    JOURNAL OF VIROLOGY, 1997, 71 (11) : 8405 - 8415
  • [48] CALCIUM-IONS ARE REQUIRED FOR CELL-FUSION MEDIATED BY THE CD4-HIV-1-ENVELOPE GLYCOPROTEIN INTERACTION
    DIMITROV, DS
    BRODER, CC
    BERGER, EA
    BLUMENTHAL, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 705 - 705
  • [49] The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
    Yamamoto, Mizuki
    Kiso, Maki
    Sakai-Tagawa, Yuko
    Iwatsuki-Horimoto, Kiyoko
    Imai, Masaki
    Takeda, Makoto
    Kinoshita, Noriko
    Ohmagari, Norio
    Gohda, Jin
    Semba, Kentaro
    Matsuda, Zene
    Kawaguchi, Yasushi
    Kawaoka, Yoshihiro
    Inoue, Jun-ichiro
    VIRUSES-BASEL, 2020, 12 (06):
  • [50] Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency
    Jayanna, Prashanth K.
    Bedi, Deepa
    Gillespie, James W.
    DeInnocentes, Patricia
    Wang, Tao
    Torchilin, Vladimir P.
    Bird, Richard C.
    Petrenko, Valery A.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (04) : 538 - 546